The Motley Fool
Australian shares to buy and hold for the next 5 yearsLet's see why analysts think these stocks could be worth holding tightly to for the remainder of the 2020s.
Posted byTelix Pharmaceuticals Ltd (ASX: TLX)
Telix is emerging as a leader in radiopharmaceuticals. It is busy building a vertically integrated model across research, isotope production, distribution, and commercialisation, aimed at maximising margins and controlling the full value chain.
Its strategy is already bearing fruit according to Bell Potter. Its analysts are forecasting further explosive earnings growth in the coming years. The broker recently said:
The company aims to initially dominate the urology space with a range of products for imaging, therapy and surgery. Valuations are attractive, with 12MF P/E now at 38x, supported by a 2yr EPS CAGR of 46%.
Bell Potter has a buy rating and $34.00 price target on the Australian share.
The Motley Fool Australian shares to buy and hold for the next 5...
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$25.75 |
Change
0.240(0.94%) |
Mkt cap ! $8.709B | |||
| Open | High | Low | Value | Volume |
| $25.51 | $26.25 | $25.51 | $31.79M | 1.227M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 116 | $25.70 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $25.80 | 1607 | 1 |
View Market Depth
| Last trade - 16.10pm 18/06/2025 (20 minute delay) ? |
| TLX (ASX) Chart |